Scynexis (SCYX) Current Deferred Revenue (2013 - 2026)
Scynexis' (SCYX) quarterly Current Deferred Revenue came in at $235000.0 in Q1 2026, down 85.69% YoY from $1.6 million in Q1 2025, and little changed on a QoQ basis from $235000.0 in Q4 2025.
Scynexis (SCYX) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 11 years of Current Deferred Revenue data on file, last reported at $235000.0 in Q1 2026.
- Quarterly Current Deferred Revenue fell 85.69% year-over-year to $235000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $235000.0 (down 85.69% YoY) and the FY2025 annual result came in at $235000.0, down 85.31% from the prior year.
- Current Deferred Revenue held at $235000.0 in Q1 2026, from $235000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $3.2 million in Q2 2023 to a low of $235000.0 in Q4 2025.
- A 4-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2025 — Current Deferred Revenue jumped 91.67% — and 2026, when it tumbled 85.69%.
- Tracing SCYX's Current Deferred Revenue over 4 years: stood at $1.2 million in 2023, then surged by 34.57% to $1.6 million in 2024, then tumbled by 85.31% to $235000.0 in 2025, then changed by 0.0% to $235000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $235000.0 (Q1 2026), $235000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,000.00 |
| Dec 31, 2025 | 235,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2019 | 54,000.00 |
| Dec 31, 2018 | 121,000.00 |
| Sep 30, 2018 | 185,000.00 |
| Jun 30, 2018 | 249,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | 257,000.00 |
| Sep 30, 2017 | 257,000.00 |
| Jun 30, 2017 | 257,000.00 |